[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nucana Plc ADR (NCNA)

Nucana Plc ADR (NCNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,785
  • Shares Outstanding, K 4,162
  • Annual Sales, $ 0 K
  • Annual Income, $ -38,710 K
  • EBIT $ -29 M
  • EBITDA $ -29 M
  • 60-Month Beta 2.25
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.19

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2100 +8.26%
on 07/29/26
1.4899 -12.07%
on 07/10/26
-0.0500 (-3.68%)
since 07/02/26
3-Month
1.2100 +8.26%
on 07/29/26
2.3900 -45.19%
on 05/29/26
-0.8800 (-40.18%)
since 05/05/26
52-Week
1.2100 +8.26%
on 07/29/26
8.6000 -84.77%
on 08/06/25
-7.1900 (-84.59%)
since 08/05/25

Most Recent Stories

More News
NuCana Reports Promising Clinical Data for NUC-3373

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Nucana (...

NCNA : 1.3150 (-5.40%)
RLYB Ends Pregnancy-Related Rare Disease Program, Stock Tanks

Shares of Rallybio Corporation RLYB tanked 41.2% on April 8 after the company announced its decision to stop the development of RLYB212 for the prevention of fetal and neonatal alloimmune thrombocytopenia...

FOLD : 14.49 (+0.21%)
RLYB : 16.15 (+1.16%)
ANIP : 79.87 (+0.85%)
NCNA : 1.3150 (-5.40%)
NuCana plc Reports Encouraging Clinical Data for NUC-7738 and NUC-3373, Highlights Financial Position and Future Milestones

NuCana reported encouraging results for NUC-7738 and NUC-3373 in recent clinical trials, with financial updates and a projected cash runway.Quiver AI SummaryNuCana plc announced encouraging Phase 2 results...

NCNA : 1.3150 (-5.40%)

Business Summary

NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The company's pipeline of products includes Acelarin, NUC-3373 and NUC-7738 which are in clinical stage. NuCana PLC is based in...

See More

Key Turning Points

3rd Resistance Point 1.4440
2nd Resistance Point 1.4220
1st Resistance Point 1.4060
Last Price 1.3150
1st Support Level 1.3680
2nd Support Level 1.3460
3rd Support Level 1.3300

See More

52-Week High 8.6000
Fibonacci 61.8% 5.7770
Fibonacci 50% 4.9050
Fibonacci 38.2% 4.0330
Last Price 1.3150
52-Week Low 1.2100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.